Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Inspiration Healthcare Group Plc LSE:IHC London Ordinary Share GB00BXDZL105 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 114.00 112.00 116.00 114.00 114.00 114.00 194,782 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 37.0 3.1 5.1 22.4 78

Inspiration Healthcare Share Discussion Threads

Showing 551 to 572 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
05/5/2020
11:33
So at £3.5m for UK and Ireland and £35m for global revenues, this looks to be a decent revenue stream for IHC. Unlike a normal Distributor, IHC are tasked with introducing the test to it's network of experts and opinion leaders to get acceptance of the test as the standard of care in Neonatal ICUs so I would hope they will receive a greater margin than just for distributing the products. Not sure this news has sunk in, looking at the current share price
troutisout
05/5/2020
11:32
From the IHC RNS, "Neil Campbell, Chief Executive Officer of Inspiration Healthcare commented "We are delighted to be able to work with genedrive plc with this novel testing device for new born babies that could suffer hearing loss due to anti-biotics given to them on admission into neonatal intensive care. Our focus has always been products that can have a profound effect on the patient outcome and we look forward to working with genedrive to make this test the standard of care in the UK and the wider neonatal community around the world." "David Budd, Chief Executive Officer of genedrive plc, said: "Our agreement with Inspiration Healthcare combines genedrive's innovative first-to-market AIHL product, with a thought leading healthcare company with a specialist emphasis on neonatal care. Inspiration Healthcare has a strong track record in the introduction of new technologies and over many years they have developed an extensive network of key opinion leaders that will be very beneficial as we bring the Genedrive AIHL test to market together."
troutisout
05/5/2020
11:31
This was in the Genedrive placing RNS today, note the projected revenues for this test. "Antibiotic-Induced Hearing Loss ("AIHL") Around one in 500 infants carry a genetic mutation that's puts them at risk of suffering lifelong profound hearing loss after exposure to gentamycin, a commonly used antibiotic. genedrive has developed world's first rapid point-of-care genetic test for neonatal intensive care. There are no other point-of-care tests commercially available for AIHL and the Directors believe genedrive's test could support a new standard of care for all urgent case infants. genedrive's AIHL test has a high clinical accuracy with 100% sensitivity and 100% specificity. Implementation trials for the test are progressing at Manchester and Liverpool but, as announced on 25 March 2020, have not been able to continue at the same pace as previous months as a result of NHS resources being diverted to address COVID-19. On 24 April 2020, genedrive announced that it had entered into a distribution agreement with Inspiration Healthcare Group plc for the distribution of genedrive's AIHL test in the UK and Ireland. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive┬« unit and £35 per test."
troutisout
04/5/2020
10:28
Geovest, Thank you very much. A knowledgeable contribution in an atmosphere of lots of short wave noise. Good stuff. Forecast PE looks much better. I haven't used EV/EBITDA - I wil run it over some of my stocks and see how it looks! Kind regards, G.
garth
04/5/2020
10:21
There's going to be plenty of testing for covid19 in the future, either to show those who have had it, and those who might have it ... And there are many companies claiming to have/looking to develop theses tests ... But there is a company, EKF Diagnostics(EKF) That would benefit greatly from any/all companies involved in this covid19 gold rush, by supplying the 'Picks and Shovels' needed.. DYOR!
grannyboy
04/5/2020
10:02
Garth, for the sake of clarity: Your PE of 28 is based on last years basic results which included exceptional cost (acquisition cost of Vio and write down of investment in Neuroprotexion, both which are really exceptional cost). Excluding this underlying EPS was 3.4p and next year forecast is 4.2. That gives a historic PE of 18 and a Forecast PE of 15. Sometimes a better and more consistent comparison between companies is to look at Enterprise value/EBITDA. Forecast EV/EBITDA is 10, which is relatively cheap. There has been a lot of speculation and hot air around this company in the last few weeks, just look at the number of posts since Feb on both threads compared to the number since listing. Thankfully the rampers and trolls have now departed (mostly). Forget ventilators etc, they are one-off and probably low margin. This is an interesting business in a specialised field. Some good products, good relationships and interesting pipeline of product development. Good long term potential but at a 10 - 15% growth per year plus potential acquisitions. Good as a long term investment, not for those looking to trade.
geovest
03/5/2020
14:09
28x earnings. Not cheap. About 15% cash. Genuinely interested if someone wants to take the time to justify what looks like a heady rating - even in a strong market. G.
garth
03/5/2020
09:41
hxxps://oilprice.com/Latest-Energy-News/World-News/Marathon-Oil-Lays-Off-200-Employees.html
astorcourt
03/5/2020
09:35
Agree Trout - a frustrating share! However I believe it will hit 90-100p later this year on results. This is an investment rather than a speculative share, so the herd have moved on looking for bumper returns from the CV19 gold rush. I'd like to see more orders (obviously) but also more guidance from the company on the value of orders. However, suspect we wont get this as this is a decent company that doesn't want to be seen to be profiteering from the increeased NHS demand. Its a buy and hold for me, and at 60-65p represents excellent value. Rich
lammylover
01/5/2020
15:32
Well today has been a damp squib, there has been more buying interest since late morning, but not enough interest to think about a breakout. It will happen soon (the chart suggests the beginning of May). The confirmation of delivery of first consignment is brilliant, as the Govt have been rather shaky on their Ventilator orders and these were sourced from overseas and so will have been hard to source and get shipped...A job well done by IHC and will be respected by the NHS for coming up with the goods. Hopefully also with many countries seeing a drop in hospitalisations the remaining order can be sorted shortly.
troutisout
01/5/2020
08:27
Well was watching it, the herd seemed to had moved on with just the remnants selling off small amounts, some larger buys went through. But after great news and strong results just felt this was too low and that a move would happen. My fear was it could be down, maybe due to inability to fulfill NHS ventilator orders in these times. Or it could rise on further news. Today we have confirmation they are fulfilling the NHS orders (no Dyson here) and that they are extending their 24 hour helpline to all of the NHS ventilators. That will bring some revenue in, but more importantly think about the networking and future potential due to this....If these are the experts you call when you need technical advice, why not call them when you are ordering your next ventilators...."Whats that you provide other intensive care equipment?"...."Neo Natal ventilators and more as well?"...That potential growth from this is huge....
troutisout
30/4/2020
12:59
It's going to break out of the coiled spring soon, 60.4p to buy at present, close to bottom of the channel and 52 week lows....Results were good, progress is good, they are in a very busy space at the moment.....I suspect we are due a positive re-rate now the traffic has died down... free stock charts from uk.advfn.com free stock charts from uk.advfn.com
troutisout
28/4/2020
20:48
Dan, Ventilator demand will be huge around the World over the next months/year... Ventilators will be made and sold Worldwide and stocks will be increased in all countries. However IHC has stated that their underlying business, especially the Neo Natal equipment will continue Covid or not, as babies are born with complications every day, there may also be a lockdown boost in births next year. Where IHC will benefit apart from the NHS contracts to supply ventilators, is their participation with UK Ventilator Challenge, supplying the breathing circuits to the Penlon units and also contracted to man a 24/7 helpline for all units supplied by UK Ventilator Challenge. The networking benefits will reap rewards for years to come for the Company and it's business.
troutisout
28/4/2020
15:10
News/update due out very soon on further contracts is what I'm hearing ....trying to buy in any volume is difficult and the price drop today is allowing mm's to accumulate ready for the next rise... I'm holding for £1 plus... silly price at this level!
smokey32
28/4/2020
13:42
Great work tole fill your boots at these daft prices!
lammylover
28/4/2020
13:40
Well I've bought back in again today fwiw.
tole
28/4/2020
12:32
Market makers use every opportunity to drive this down below 60p. Typical day today, low volume <100k trades in morning, a few more sells than buys, so MMs drop bid hard to 58p to shake out weak hand holders and generate volume so they can get their commission / margin. Lots of buys, but MMs still keep bid low, hoping to shake out even more holders who are worried that share has dropped 7% with no news...., then eventually MMs will start to move price back up again. Rinse and repeat on a regular basis..... Buy and hold, this is easily worth 90p+ in my opinion. DYOR Rich
lammylover
26/4/2020
07:45
Fake news. Disgusting how some people relish in the (fake) death of others. Shocking and sick!
jfrost1969
23/4/2020
15:30
So why vent your spleen here, do it on the BVC board.
geovest
23/4/2020
15:30
BATM are showing as £243m marketcap on the quote pg, what debt (if any) do they have to add to that. Whatever makes these at nearly £24m cap look like they may have room to run too.
bad gateway
23/4/2020
14:12
you missing the point, BVC making much more profits form ventilators, not IHC making bits and pops
rumobejo
23/4/2020
14:03
£5m order from NHS to IHC was independent of UK Consortium work. IHC should make a profit off this first order of ventillators from Israel. The work alongside the UK consortium won't be profitable, but will be useful in cementing IHC's name with the NHS buyers of essential equipment.
lammylover
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
ADVFN Advertorial
Your Recent History
LSE
IHC
Inspiratio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210725 10:42:44